SAN DIEGO, Aug. 8, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Canaccord Genuity 33rd Annual Growth Conference on Thursday, August 15.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 8:00 a.m., Eastern Daylight Time (5:00 a.m., Pacific Daylight Time). The presentation will be available through http://wsw.com/webcast/canaccord10/VOLC and via the company's website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation